determine the prevalence of sarcopenia and investigate how sarcopenia is associated with risk factors for adverse clinical outcomes: older age and male sex [10], nutritional risk and low albumin, low vitamin D, low body mass index (BMI) [25], comorbidities and polypharmacy, and impairments in activities of daily living [26]. The gene discussed is ALB; the disease is sarcopenia.